Role of lipoteichoic acid in the phagocyte response to group B Streptococcus

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6449-6455

  Henneke, Philipp ^a   Morath, Siegfried ^b   Uematsu, Satoshi ^d   Weichert, Stefan ^a   Pfitzenmaier, Markus ^c   Takeuchi, Osamu ^d   Müller, Andrea ^a   Poyart, Claire ^e   Akira, Shizuo ^d   Berner, Reinhard ^a   Teti, Giuseppe ^g   Geyer, Armin ^c   Hartung, Thomas ^b   Trieu Cuot, Patrick ^f   Kasper, Dennis L ^h   Golenbock, Douglas T ⁱ  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d OSAKA UNIVERSITY   (Japan)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f INSTITUT PASTEUR   (France)

^g UNIVERSITY OF MESSINA   (Italy)

^h BRIGHAM AND WOMEN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; GLYCEROPHOSPHATE; GLYCOLIPID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOTEICHOIC ACID; N ACETYLGLUCOSAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; WORTMANNIN;

ANIMAL CELL; ARTICLE; BACTERIAL CELL WALL; CELL STRAIN HEK293; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; STREPTOCOCCUS AGALACTIAE; STRUCTURE ANALYSIS;

EID: 20844461891     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6449     Document Type: Article

References (48)

1. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, B. A. Perkins, and the Active Surveillance Team. 1997. Bacterial meningitis in the United States in 1995. N. Engl. J. Med. 337: 970-976.
2. Persson, K. M., B. Bjerre, L. Elfstrom, S. Polberger, and A. Forsgren. 1986. Faecal carriage of group B streptococci. Eur. J. Clin. Microbiol. 5: 156-159.
3. Henneke, P., O. Takeuchi, J. A. van Strijp, H.-K. Guttormsen, J. A. Smith, A. B. Schromm, T. A. Espevik, S. Akira, V. Nizet, D. L. Kasper, and D. T. Golenbock. 2001. Novel engagement of CD14 and multiple Toll-like receptors by group B streptococci. J. Immmunol. 167: 7069-7076.
4. Henneke, P., O. Takeuchi, R. Mattey, E. Lien, R. R. Ingalls, M. W. Freeman, T. Mayadas, V. Nizet, S. Akira, D. L. Kasper, and D. T. Golenbock. 2002. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J. Immunol. 169: 3970-3977.
5. Mancuso, G., A. Midiri, C. Beninati, C. Biondo, R. Galbo, S. Akira, P. Henneke, D. Golenbock, and G. Teti. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172: 6324-6329.
6. Neuhaus, F. C., and J. Baddiley. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in Gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67: 686-723.
7. Janeway, C. A., Jr. 1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol. Today 13: 11-16.
8. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163: 1-5.
9. Kaneko, T., W. E. Goldman, P. Mellroth, H. Steiner, K. Fukase, S. Kusumoto, W. Harley, A. Fox, D. Golenbock, and N. Silverman. 2004. Monomeric and polymeric Gram-negative peptidoglycan but not purified LPS stimulate the Drosophila IMD pathway. Immunity 20: 637-649.
10. Man, S. H., J. H. Kim, M. Martin, S. M. Michalek, and M. H. Nahm. 2003. Pneumococcal lipoteichoic acid (LTA) is not as potent as staphylococcal LTA in stimulating Toll-like receptor 2. Infect. Immun. 71: 5541-5548.
11. Travassos, L. H., S. E. Girardin, D. J. Philpott, D. Blanot, M. A. Nahori, C. Werts, and I. G. Boneca. 2004. Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Rep. 5: 1000-1006.
12. Flo, T, H., O. Halaas, E. Lien, L. Ryan, G. Teti, D. T. Golenbock, A. Sundan, and T. Espevik. 2000. Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J. Immunol. 164: 2064-2069.
13. Poyart, C., M. C. Lamy, C. Boumaila, F. Fiedler, and P. Trieu-Cuot. 2001. Regulation of D-alanyl-lipoteichoic acid biosynthesis in Streptococcus agalactiae involves a novel two-component regulatory system. J. Bacteriol. 183: 6324-6334.
14. Poyart, C., E. Pellegrini, M. Marceau, M. Baptista, F. Jaubert, M. C. Lamy, and P. Trieu-Cuot. 2003. Attenuated virulence of Streptococcus agalactiae deficient in D-alanyl-lipoteichoic acid is due to an increased susceptibility to defensins and phagocytic cells. Mol. Microbiol. 49: 1615-1635.
15. Paoletti, L. C., R. A. Ross, and K. D. Johnson. 1996. Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide. Infect. Immun. 64: 1220-1226.
16. Morath, S., A. Geyer, and T. Hartung. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J. Exp. Med. 193: 393-397.
17. Takeuchi, O., S. Sato, T. Horiuchi, K. Hoshino, K. Takeda, Z. Dong, R. L. Modlin, and S. Akira. 2002. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169: 10-14.
18. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165: 5392-5396.
19. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451.
20. Moore, K. J., L. P. Andersson, R. R. Ingalls, B. G. Monks, R. Li, M. Amin Arnaout, D. T. Golenbock, and M. W. Freeman. 2000. Divergent response to LPS and bacteria in CD14-deficient murine macrophages. J. Immunol. 165: 4272-4280.
21. Coxon, A., P. Rieu, F. J. Barkalow, S. Askari, A. H. Sharpe, U. H. von Andrian, M. Amin Arnaout, and T. N. Mayadas. 1996. A novel role for the β2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity 5: 653-666.
22. Arbibe, L., J. P. Mira, N. Teusch, L. Kline, M. Guha, N. Mackman, P. J. Godowski, R. J. Ulevitch, and U. G. Knaus. 2000. Toll-like receptor 2-mediated NFκB activation requires a Rac1-dependent pathway. Nat. Immunol. 1: 533-540.
23. Takeuchi, O., T. Kawai, H. Sanjo, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, K. Takeda, and S. Akira. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231: 59-65.
24. Ozinsky, A., K. D. Smith, D. Hume, and D. M. Underbill. 2000. Co-operative induction of pro-inflammatory signaling by Toll-like receptors. J. Endotoxin Res. 6: 393-396.
25. Rubens, C. E., H. V. Raff, J. C. Jackson, E. Y. Chi, J. T. Bielitzki, and S. L. Hillier. 1991. Pathophysiology and histopathology of group B streptococcal sepsis in Macaca nemestrina primates induced after intraamniotic inoculation: evidence for bacterial cellular invasion. J. Infect. Dis. 164: 320-330.
26. Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-κB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol. 160: 4535-4542.
27. Henneke, P., I. Osmers, K. Bauer, N. Lamping, H. T. Versmold, and R. R. Schumann. 2003. Impaired CD14-dependent and independent response of polymorphonuclear leukocytes in preterm infants. J. Perinat. Med. 31: 176-183.
28. Marodi, L., R. Kaposzta, and E. Nemes. 2000. Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant γ interferon and granulocyte-macrophage colony-stimulating factor. Infect. Immun. 68: 2167-2170.
29. Ptak, W., M. Klimek, K. Bryniarski, M. Ptak, and P. Majcher. 1998. Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals. Clin. Exp. Immunol. 114: 13-18.
30. Schroder, N. W., S. Morath, C. Alexander, L. Hamann, T. Hartung, U. Zahringer, U. B. Gobel, J. R. Weber, and R. R. Schumann. 2003. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14. whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278: 15587-15594.
31. Morath, S., A. Stadelmaier, A. Geyer, R. R. Schmidt, and T. Härtung. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J. Exp. Med. 195: 1635-1640.
32. Hashimoto, M., J. Yasuoka, Y. Suda, H. Takada, T. Yoshida, S. Kotani, and S. Kusumoto. 1997. Structural feature of the major but not cytokine-inducing molecular species of lipoteichoic acid. J. Biochem. 121: 779-786.
33. Ozinsky, A., D. M. Underbill, J. D. Fontenot, A. M. Hajjar, K. D. Smith. C. B. Wilson, L. Schroeder, and A. Aderem. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97: 13766-13771.
34. Takeuchi O., T. Kawai, P. F. Mühlradt, M. Morr, J. D. Radolf, A. Zychlinsky. K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13: 933-940.
35. Maurer, J. J., and S. J. Mattingly. 1991. Molecular analysis of lipoteichoic acid from Streptococcus agalactiae. J. Bacteriol. 173: 487-494.
36. Leopold, K., and W. Fischer. 1991. Separation of the poly(glycerophosphate) lipoteichoic acids of Enterococcus faecalis Kiel 27738, Enterococcus hirae ATCC 9790 and Leuconostoc mesenteroides DSM 20343 into molecular species by affinity chromatography on concanavalin A. Eur. J. Biochem. 196: 475-482.
37. Morath, S., A. Geyer, I. Spreitzer, C. Hermann, and T. Hartung. 2002. Structural decomposition and heterogeneity of commercial lipoteichoic acid preparations. Infect. Immun. 70: 938-944.
38. Kengatharan, K. M., S. De Kimpe, C. Robson, S. J. Foster, and C. Thiemermann. 1998. Mechanism of Gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. J. Exp. Med. 188: 305-315.
39. Korhonen, R., R. Korpela, M. Saxelin, M. Mäki, H. Kankaanranta, and E. Moilanen. 2001. Induction of nitric oxide synthesis by probiotic Lactobacillus rhamnosus GG in J774 macrophages and human T84 intestinal epithelial cells. Inflammation 25: 223-232.
40. Debabov, D. V., M. Y. Kiriukhin, and F. C. Neuhaus. 2000. Biosynthesis of lipoteichoic acid in Lactobacillus rhanmosus: role of DUD in D-alanylation. J. Bacteriol. 182: 2855-2864.
41. Wang, J. E., P. F. Jorgensen, M. Almlof, C. Thaemennann, S. J. Foster, A. O. Aasen, and R. Solberg. 2000. Peptidoglycan and lipoteichoic acid from Staphylococcus aureus induce tumor necrosis factor α, interleukin 6 (IL-6), and IL-10 production in both T cells and monocytes in a human whole blood model. Infect. Immun. 68: 3965-3970.
42. Ginsburg, I. 2002. The role of bacteriolysis in the pathophysiology of inflammation, infection and post-infectious sequelae. Apmis 110: 753-770.
43. Middelveld, R. J., and K. Alving. 2000. Synergistic septicemic action of the Gram-positive bacterial cell wall components peptidoglycan and lipoteichoic acid in the pig in vivo. Shock 13: 297-306.
44. Takeuchi, O., T. Kawai, P. F. Muhlradt, M. Morr, J. D. Radolf, A. Zychlinsky, K. Takeda, and S. Akira. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13: 933-940.
45. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92: 10359-10363.
46. Beutler, E., T. Gelbart, and C. West. 2001. Synergy between TLR2 and TLR4: a safety mechanism. Blood Cells Mol. Dis. 27: 728-730.
47. Sato, S., F. Nomura, T. Kawai, O. Takeuchi, P. F. Mühlradt, K. Takeda, and S. Akira. 2000. Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 165: 7096-7101.
48. Gao, J. J., Q. Xue, E. G. Zuvanich, K. R. Haghi, and D. C. Morrison. 2001. Commercial preparations of lipoteichoic acid contain endotoxin that contributes to activation of mouse macrophages in vitro. Infect. Immun. 69: 751-757.